patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: That is until you look at the shareregister

SU..learn to spell :) you spell like a basher..Dr. Schein wouldn't join

posted on Aug 08, 2007 06:55AM

the business advisory board of this company and sully his reputation, nor would Frank Carlucci own 4.1% of this company for the same reason

best check out the PLRS scientific advisory board of pre-emminent doctors

Share
New Message
Please login to post a reply